Stoneridge Investment Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,896
Closed -$1.26M 127
2025
Q2
$1.26M Buy
+13,896
New +$1.27M 0.95% 34
2019
Q2
Sell
-47,272
Closed -$3.24M 122
2019
Q1
$3.24M Buy
+47,272
New +$3.05M 0.95% 43
2018
Q4
Sell
-22,091
Closed -$1.48M 123
2018
Q3
$1.48M Sell
22,091
-2,707
-11% -$180K 0.31% 88
2018
Q2
$1.61M Sell
24,798
-98,338
-80% -$6.43M 0.31% 84
2018
Q1
$8.83M Buy
+123,136
New +$8.86M 1.48% 13
2017
Q4
Sell
-24,331
Closed -$1.77M 229
2017
Q3
$1.77M Buy
+24,331
New +$1.75M 0.28% 103

Other funds holding CL

Stoneridge Investment Partners's CL Position: Q3 2025 in Review

Stoneridge Investment Partners sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 13,896 shares — an estimated $1.26M sold.

Stoneridge Investment Partners first reported a position in CL in Q3 2017 and held it in 6 quarters. The position peaked at $8.83M in Q1 2018. 1,846 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • Stoneridge Investment Partners reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
  • Stoneridge Investment Partners sold 13,896 Colgate-Palmolive shares in Q3 2025, an estimated $1.26M.
  • Stoneridge Investment Partners first reported a position in Colgate-Palmolive in Q3 2017 and held it in 6 quarters.
  • Stoneridge Investment Partners's Colgate-Palmolive position peaked at $8.83M in Q1 2018.
  • 1,846 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Stoneridge Investment Partners's 13F filing for Q3 2025, filed 31 Oct 2025.